Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154346 · ClinicalTrials.gov registry record
Project Baseline Health Study
A clinical trial of ALL, sponsored by Baseline Study.
- Active
- Registry status
- 10,000
- Enrollment target
- 5
- Study locations
NCT03154346 is a study of ALL that is active but no longer recruiting, run by Baseline Study. The registered enrollment target is 10,000 participants, above the 192-participant average among 13 other ALL trials with a reported enrollment target (5108% higher). The trial reports 5 study locations across 2 states.
The verdict
NCT03154346, a study of ALL, is active but no longer recruiting, sponsored by Baseline Study.
- ACTIVE NOT RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is the first initiative of Project Baseline, a broader effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease. Project Baseline endeavors to test and develop new tools and technologies to collect, organize, and activate health information.
Conditions Studied
Study Locations (5)
California
- Baseline Study - South San Francisco
- Stanford Medicine - Stanford
- California Health and Longevity Institute - Westlake Village
North Carolina
- Duke University School of Medicine - Durham
- Duke University School of Medicine - Kannapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2024-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03154346
The ClinicalTrials.gov registry entry for NCT03154346 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 192-participant average among 13 other ALL trials with a reported enrollment target (5108% higher). The listed sponsor is Baseline Study, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ALL appearing as the primary indexed condition, and to 0 interventions.
NCT03154346 reports 5 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03154346 about?
NCT03154346 is a clinical study titled "Project Baseline Health Study". This study is the first initiative of Project Baseline, a broader effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for di...
What is the current status of trial NCT03154346?
This trial is currently active not recruiting. The enrollment target is 10,000 participants. The study started on 2017-03-29. Estimated completion is 2024-12.
What conditions does trial NCT03154346 study?
This clinical trial studies the following conditions: ALL.
Who is sponsoring clinical trial NCT03154346?
This trial is sponsored by Baseline Study, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03154346 being conducted?
This trial has 5 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
RECRUITING · Phase 1
-
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RECRUITING · Phase 1
-
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RECRUITING
-
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
RECRUITING · Phase 2
-
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
RECRUITING · Phase 1
-
A Long Term Follow-up Study of TScan TCR-T Products
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.